Pharmacokinetics in Vitro and in Vivo of Two Novel Prodrugs of Oleanolic Acid in Rats and Its Hepatoprotective Effects against Liver Injury Induced by CCl4
文献类型：期刊论文
| 作者 | Yu, Zongjiang1; Sun, Weizhi2 ; Peng, Weibing1; Yu, Rilei1; Li, Guoqiang1; Jiang, Tao1
|
| 刊名 | MOLECULAR PHARMACEUTICS
 |
| 出版日期 | 2016-05-01 |
| 卷号 | 13期号:5页码:1699-1710 |
| 关键词 | oleanolic acid (OA) prodrug hepatoprotective pharmacokinetics biodistribution |
| 英文摘要 | Oleanolic acid (OA) is a well-known pentacyclic triterpenoid compound, which has been used as a dietary supplement and is supplied as an over-the-counter drug for the treatment of human liver diseases. These are reasons for the low bioavailability of OA which have restricted its wider application. In this study, two OA prodrugs (1,3-cyclic propanyl phosphate esters of OA) were designed and synthesized. The hepatoprotective effects of these prodrugs were evaluated against carbon tetrachloride (CCl4) induced liver injury in mice; the levels of alanine aminotransferase (ALT), lactic dehydrogenase (LDH), and aspartate aminotransferase (AST) were significantly increased, and the level of the hepatic malondialdehyde (MDA) was increased. The metabolism, in vitro, of the prodrugs was studied by incubation in rat liver microsome; the plasma pharmacokinetics and the biodistribution in vivo after intravenous (iv) injection to six rats were investigated, respectively. The prodrugs diminished gradually with time; most of the parent drugs were released within 30 min in vitro, and the presumed mechanism of the in vitro metabolism was confirmed. The plasmaconcentration data in vivo was analyzed by a compartmental method: both the prodrugs and the corresponding released parent drugs existed at up to 48 h in rats. The t1/2 improved after intravenous administration in rats compared with direct injection of the parent drugs. All analyte concentrations were highest in the liver, and most of the prodrugs were excreted in feces (>47.11%). Therefore, 1,3-cyclic propanyl phosphate esters of OA can serve as a promising lead candidate for drugs. |
| WOS标题词 | Science & Technology ; Life Sciences & Biomedicine |
| 类目[WOS] | Medicine, Research & Experimental ; Pharmacology & Pharmacy |
| 研究领域[WOS] | Research & Experimental Medicine ; Pharmacology & Pharmacy |
| 关键词[WOS] | PROPANYL PHOSPHATE ESTER ; MICE ; METABOLISM ; DERIVATIVES ; EXTRACT ; SERUM ; MICROSOMES ; DESIGN ; PLASMA ; FECES |
| 收录类别 | SCI |
| 语种 | 英语 |
| WOS记录号 | WOS:000375519600026 |
| 源URL | [http://ir.qibebt.ac.cn/handle/337004/8319]  |
| 专题 | 青岛生物能源与过程研究所_材料生物技术研究中心 |
| 作者单位 | 1.Ocean Univ China, Sch Pharm, Minist Educ China, Key Lab Marine Drugs, Qingdao 266003, Peoples R China 2.Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, CAS Key Lab Biobased Mat, Qingdao 266101, Peoples R China |
| 推荐引用方式 GB/T 7714 | Yu, Zongjiang,Sun, Weizhi,Peng, Weibing,et al. Pharmacokinetics in Vitro and in Vivo of Two Novel Prodrugs of Oleanolic Acid in Rats and Its Hepatoprotective Effects against Liver Injury Induced by CCl4[J]. MOLECULAR PHARMACEUTICS,2016,13(5):1699-1710. |
| APA | Yu, Zongjiang,Sun, Weizhi,Peng, Weibing,Yu, Rilei,Li, Guoqiang,&Jiang, Tao.(2016).Pharmacokinetics in Vitro and in Vivo of Two Novel Prodrugs of Oleanolic Acid in Rats and Its Hepatoprotective Effects against Liver Injury Induced by CCl4.MOLECULAR PHARMACEUTICS,13(5),1699-1710. |
| MLA | Yu, Zongjiang,et al."Pharmacokinetics in Vitro and in Vivo of Two Novel Prodrugs of Oleanolic Acid in Rats and Its Hepatoprotective Effects against Liver Injury Induced by CCl4".MOLECULAR PHARMACEUTICS 13.5(2016):1699-1710. |
入库方式： OAI收割
来源：青岛生物能源与过程研究所
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。